Added to YB: 2024-08-06
Pitch date: 2024-07-18
PRCT [bullish]
PROCEPT BioRobotics Corporation
-46.38%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
Market Cap
$3.7B
Pitch Price
$67.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-37.64
P/E
-34.68
EV/Sales
17.73
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Next Century Growth Investors NCG SMID CAP New Position: PROCEPT BioRobotics Corporation
PRCT: Robotic BPH treatment device maker. Strong growth potential via market share gain, expanding BPH patient base, and future prostate cancer treatment. Innovative tech poised to disrupt existing BPH market and create new opportunities in urology.
Read full article (1 min)